查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840858

智慧切片检查设备市场按产品类型、应用、引导技术、最终用户和组件划分－2025年至2032年全球预测

Smart Biopsy Devices Market by Product Type, Application, Guidance Technology, End User, Component - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，智慧切片检查设备市场规模将达到 91.1 亿美元，复合年增长率为 6.52%。

关键市场统计数据
基准年 2024 54.9亿美元
预计年份：2025年 58.5亿美元
预测年份 2032 91.1亿美元
复合年增长率 (%) 6.52%

一份简明指南，阐述了影像创新、手术效率和临床需求如何融合，从而塑造现代切片检查设备策略。

智慧切片检查设备的发展现况是临床需求与技术能力相互融合的产物，需要精心的策略规划。影像技术、针头设计和引导软体的进步正在提高诊断准确性，同时也在重塑医疗机构的流程。随着临床医生追求微创手术，以期获得更好的组织采集效果并降低患者风险，设备开发商和医疗系统也在积极转型，透过整合自动化平台、即时影像引导和可互通的软体栈，简化规划、导航和文件记录流程。

在此背景下，监管和报销途径持续影响着产品开发进度和市场接受度，使得供应链韧性和零件采购成为一项准策略性要务。因此，从製造商到医院采购团队的相关人员必须在临床性能、可製造性、成本和售后支援之间取得平衡。此外，来自相邻诊断成像和手术导引市场的技术创新相互借鉴，正在加速产品功能集的完善，并催生以分析和结果追踪为中心的新型经营模式。

综上所述，这些动态凸显了高阶主管整合的重要性，这种整合既要关注近期运营，又要关注长期战略布局——为决策者提供简洁而全面的指导，帮助他们了解影响设备发展的各种因素、推动临床应用的因素，以及在日益复杂的生态系统中保持优势所需的竞争应对措施。

技术、临床工作流程和商业性的重大变革正在重塑切片检查设备的竞争定位和市场推广路径。

过去几年，临床实践和产品开发领域发生了加速的变革性转变，从根本上改变了智慧切片检查设备的竞争格局。首先，影像引导探查已从辅助功能转变为核心功能，推动了硬体、软体和资料分析之间更深层的整合。因此，製造商优先开发模组化平台，这些平台可容纳多种影像输入，并能透过回馈迴路实现确定性的针头定位，从而减少操作者之间的差异。

其次，工作流程优化已成为一项商业性差异化因素。能够缩短手术时间、降低併发症发生率并简化文件记录的程序正在被系统层面广泛采用。因此，以使用者为中心的介面、自动针头定位选项以及支援流程标准化的云端文件等设计理念正变得日益重要。第三，与数位医疗的整合正在催生新的可获利服务（软体即服务模式、影像分析订阅、结果追踪模组），以增加设备收入并深化客户关係。

最后，竞争格局正在改变。规模较小、反应更敏捷的参与企业正致力于开发小众临床应用或新型针头几何形状，而成熟的医疗技术公司则利用其规模优势，将设备、成像系统和服务协议捆绑销售。影像处理供应商、软体开发商和手术设备製造商之间的伙伴关係日益普遍，这反映出人们认识到，在复杂的临床路径中，整合解决方案才是致胜之道。总而言之，这些变化要求相关人员重新思考其产品蓝图、临床检验策略和市场推广模式，以实现临床价值和经济效益的双重提升。

2025 年关税调整如何影响医疗器材製造和临床应用路径的供应链、采购行为和产品策略

2025年宣布的一系列关税措施的累积影响，对智慧切片检查价值链的供应链配置和成本结构产生了切实的营运和策略影响。影响医疗设备组件和精密合金的关税迫使製造商重新评估其供应商组合，加快在免税地区的供应商资质认证，并考虑本地组装以降低不断上涨的土地成本。由于企业试图规避供应中断和财务不确定性，这些调整往往导致计划管理成本增加和库存积压。

此外，关税环境也影响了终端使用者的采购行为。面对资本预算的限制，医院和诊断中心越来越关注整体拥有成本（不仅包括购买成本，还包括维护、耗材以及设备选择带来的后续影响）。为此，供应商优先考虑提高组件采购和生命週期成本的透明度，一些供应商还提案替代性的商业条款，例如耗材捆绑包和服务捆绑协议，以保持竞争力。

从产品创新角度来看，关税情势正在加速两种显着的因应措施。首先，在临床可接受的情况下，开发人员正在寻求简化设计和材料替代，以减少对高关税投入品的依赖。其次，他们优先考虑透过对关税波动不敏感的软体和服务层来实现差异化，从而保护净利率并维持价值获取。随着企业寻求在监管合规、成本稳定和不间断的临床供应之间取得平衡，製造地转移和供应商多元化很可能仍将是积极的管理重点。

透过深度细分主导的分析，揭示产品、应用、引导技术、最终用户和组件之间的差异将如何影响临床和商业性路径。

细分市场分析提供了一种结构化的视角，用于识别临床需求、技术能力和市场机会的交集。根据产品类型，市场参与企业将平台分为自动化平台和手动平台。自动化平台提供工作流程的一致性，而手动设备则提供许多操作者熟悉的操作流程。这种二分法会影响产品设计和培训投入，因为自动化解决方案需要更紧密的软硬体集成，而手动平台则更注重人体工学和触觉回馈。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧技术应用于即时影像导引切片检查决策
  • 开发一种内建感测器的切片穿刺针，用于精确的组织表征和回馈
  • 引入机器人辅助切片检查平台将提高手术准确性和工作流程效率。
  • 即时切片检查样本分析和决策支援的照护现场综合分子诊断技术的出现
  • 磁振造影超音波融合技术在智慧切片检查系统中的应用日益广泛，用于标靶癌症检测
  • 扩展云端基础的数据管理和远端医疗集成，以进行远端切片检查程序监测
  • 监管核准和报销范围扩大将影响智慧切片检查设备市场的成长动态。
  • 用于自动病灶检测和切片检查靶点推荐的深度学习演算法的进展

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按产品类型分類的智慧切片检查设备市场

  • 自动化
  • 手动的

第九章 按应用分類的智慧切片检查设备市场

  • 胸部
  • 肝
  • 肺
  • 摄护腺

第十章：智慧切片检查设备市场指导技术

  • CT导板
  • MRI 指南
  • 超音波引导

第十一章 智慧切片检查设备市场（按最终用户划分）

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 医院

第十二章 智慧切片检查设备市场（按组件划分）

  • 配件
  • 导航软体
  • 影像系统
  • 针
    • 大轨距
    • 中型轨
    • 小轨距

第十三章 智慧切片检查设备市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 智慧切片检查设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国智慧切片检查设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • General Electric Company
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Hologic, Inc.
    • Fujifilm Holdings Corporation
    • Hitachi, Ltd.
    • Becton, Dickinson and Company
    • Cook Medical LLC
    • Merit Medical Systems, Inc.
Product Code: MRR-221461476EF5

The Smart Biopsy Devices Market is projected to grow by USD 9.11 billion at a CAGR of 6.52% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.49 billion
Estimated Year [2025] USD 5.85 billion
Forecast Year [2032] USD 9.11 billion
CAGR (%) 6.52%

A concise orientation to the convergence of imaging innovation, procedural efficiency, and clinical demand reshaping modern biopsy device strategies

The smart biopsy device landscape is converging clinical necessity and technological capability in ways that demand close strategic attention. Advances in imaging modalities, needle design, and guidance software are increasing diagnostic precision while reshaping procedural workflows across care settings. As clinicians push for minimally invasive techniques with improved tissue acquisition and reduced patient risk, device developers and health systems are adapting through integration of automated platforms, real-time imaging guidance, and interoperable software stacks that streamline planning, navigation, and documentation.

Against this backdrop, regulatory scrutiny and reimbursement pathways continue to influence product development timelines and adoption curves, while supply chain resilience and component sourcing have become quasi-strategic imperatives. Stakeholders from manufacturers to hospital procurement teams must therefore balance clinical performance with manufacturability, cost, and post-market support. In addition, the cross-pollination of innovations from adjacent imaging and surgical navigation markets is accelerating feature sets and creating new business models centered on analytics and outcomes tracking.

Taken together, these dynamics underscore the importance of a focused executive-level synthesis that highlights both the near-term operational levers and the longer-term strategic bets. The aim is to provide decision-makers with a concise yet comprehensive orientation to the forces shaping device evolution, adoption drivers across clinical settings, and the competitive responses required to maintain advantage in an increasingly sophisticated ecosystem.

Critical technological, clinical workflow, and commercial shifts that are remaking competitive positioning and adoption pathways for biopsy devices

Over the past several years, transformative shifts have accelerated in clinical practice and product development, producing a fundamentally different competitive landscape for smart biopsy devices. First, imaging-guided precision has moved from adjunctive support to a core functional requirement, driving deeper integration between hardware, software, and data analytics. As a result, manufacturers are prioritizing modular platforms that can accept multiple imaging inputs and deliver deterministic needle placement with feedback loops that reduce variability across operators.

Second, workflow optimization has become a commercial differentiator. Programs that reduce procedure time, lower complication rates, and simplify documentation attract system-level adoption. Consequently, design philosophies emphasize user-centered interfaces, automated needle deployment options, and cloud-enabled documentation that support procedural standardization. Third, convergence with digital health has introduced new monetizable services-software-as-a-service models, image analytics subscriptions, and outcome-tracking modules-that augment device revenue and deepen customer relationships.

Finally, competitive dynamics are changing as well. Smaller agile entrants are pursuing niche clinical applications and novel needle geometries, while established medtech firms leverage scale to bundle devices, imaging systems, and service contracts. Partnerships between imaging providers, software developers, and procedural device manufacturers are increasingly common, reflecting a recognition that integrated solutions win in complex clinical pathways. Altogether, these shifts demand that stakeholders rethink product roadmaps, clinical validation strategies, and go-to-market models to capture both clinical value and economic upside.

How 2025 tariff shifts have pressured supply chains, procurement behavior, and product strategies across device manufacturing and clinical adoption pathways

The cumulative impact of tariff actions announced in 2025 has introduced tangible operational and strategic consequences for supply chain configurations and cost structures across the smart biopsy device value chain. Tariff measures affecting medical device components and precision alloys have compelled manufacturers to re-evaluate supplier portfolios, accelerate supplier qualification in tariff-exempt jurisdictions, and consider localized assembly to mitigate increased landed costs. In many cases, these adjustments introduced project management overhead and inventory build-up as firms sought to hedge against supply interruptions and fiscal uncertainty.

Moreover, the tariff environment has influenced procurement behaviors among end users. Hospitals and diagnostic centers facing constrained capital budgets have heightened scrutiny on total cost of ownership, which includes not only acquisition cost but also maintenance, consumables, and the downstream operational impact of device selection. In response, vendors have emphasized transparency around component sourcing and lifecycle costs, and some have proposed alternative commercial terms-such as consumable bundling or service-inclusive agreements-to maintain competitiveness.

From a product innovation perspective, the tariff landscape has accelerated two notable responses. One, developers are exploring design simplification and material substitution where clinically acceptable, reducing reliance on high-tariff inputs. Two, companies are prioritizing differentiation through software and service layers that are less exposed to tariff fluctuations, thereby protecting margins and preserving value capture. Transitioning manufacturing footprints and diversifying supplier bases will remain an active management priority as firms seek to balance regulatory compliance, cost stability, and uninterrupted clinical supply.

Deep segmentation-driven analysis revealing how product, application, guidance technology, end-user, and component distinctions shape clinical and commercial pathways

Segmentation analysis provides a structured lens for identifying where clinical need, technological capability, and commercial opportunity intersect. Based on Product Type, market participants differentiate offerings between Automated and Manual platforms, with automation delivering workflow consistency and manual devices offering procedural familiarity for many operators. This dichotomy informs both product design and training investments, as automated solutions require tighter software-hardware integration while manual platforms prioritize ergonomics and tactile feedback.

Based on Application, clinical focus areas span Breast, Liver, Lung, and Prostate procedures, each presenting distinct anatomic and procedural constraints that shape device requirements. Breast biopsies emphasize cosmetic outcomes and outpatient procedural efficiency; liver and lung procedures demand robust imaging guidance to navigate respiratory motion and tissue heterogeneity; prostate biopsies require high spatial accuracy to align diagnostic sampling with targeted therapy planning. These application-specific imperatives drive needle design, imaging compatibility, and clinical training curricula.

Based on Guidance Technology, devices are evaluated across CT Guided, MRI Guided, and Ultrasound Guided modalities. CT guidance offers high-resolution anatomic localization in thoracic and hepatic interventions, MRI guidance excels in soft-tissue contrast and targeted prostate procedures, and ultrasound guidance provides real-time feedback and cost-effective portability. Interoperability across these guidance technologies is increasingly important as institutions seek flexible platforms that can be deployed across multiple procedure types.

Based on End User, adoption occurs across Ambulatory Surgical Centers, Clinics, Diagnostic Centers, and Hospitals, each with unique procurement cycles, staffing models, and throughput expectations. Ambulatory surgical centers and diagnostic centers often prioritize throughput and per-procedure cost efficiency, while hospitals focus on integration with broader imaging fleets and cross-departmental support. Clinics may value compact footprint and ease of use for office-based procedures.

Based on Component, device ecosystems are comprised of Accessories, Guidance Software, Imaging Systems, and Needles. Needles are further categorized across Large Gauge, Medium Gauge, and Small Gauge variants to accommodate different tissue types, sample volume needs, and clinician preferences. Component-level differentiation-such as needle lumen design, software navigation fidelity, and accessory ergonomics-drives clinician choice and impacts re-order cycles for consumables. By mapping segmentation layers to clinical workflows, stakeholders can better prioritize R&D investments and commercialization strategies that align with end-user economics and procedural outcomes.

Comparative regional dynamics and strategic imperatives highlighting how clinical priorities, regulation, and infrastructure influence device adoption across global markets

Regional dynamics exhibit distinct clinical priorities, regulatory environments, and procurement behaviors that influence adoption patterns and partnership strategies. In the Americas, healthcare delivery systems are characterized by a high degree of specialization, advanced imaging infrastructure, and a strong emphasis on minimally invasive diagnostic pathways. These factors favor devices that demonstrate procedural efficiency, reimbursement alignment, and interoperability with existing imaging platforms. Moreover, payer sensitivity and hospital budget cycles often dictate procurement timing and the uptake of higher-cost integrated solutions.

In Europe, Middle East & Africa, heterogeneous regulatory regimes and varied capital intensity produce differentiated adoption timelines across subregions. Established markets in Western Europe prioritize conformity with stringent regulatory and safety standards, while emerging markets within the region focus on cost-effective solutions and scalable training models. Middle Eastern and African markets often present opportunities for partnership-based distribution models and localized servicing agreements, reflecting logistical complexities and diverse clinical infrastructure.

In the Asia-Pacific region, rapid investment in imaging capacity and a growing emphasis on early detection and minimally invasive care are catalyzing demand for devices that can be rapidly deployed and supported at scale. Several APAC markets are also notable for fast adoption of novel procedural workflows and for demand-driven customization to local clinical practices. Cross-border supply chain considerations and regional trade agreements further influence sourcing decisions, as manufacturers weigh proximity to growing centers of demand against manufacturing cost advantages. Overall, regional strategy must be adaptive, combining regulatory pathway planning with tailored commercial models that reflect local payer systems, clinical practice patterns, and infrastructure maturity.

Competitive landscape and partnership strategies that differentiate leaders through clinical evidence, integrated services, and scalable commercialization models

Competitive dynamics in the smart biopsy domain are shaped by a mix of established medical device firms, imaging system providers, nimble startups focused on niche procedural needs, and software-first companies that deliver navigation and analytics capabilities. These players differentiate through clinical evidence generation, system integration, after-sales service, and strategic partnerships. Firms that can demonstrate clear outcomes advantages-reduced complication rates, higher diagnostic yield, or improved workflow efficiency-tend to build stronger institutional relationships and justify premium contracting models.

In addition to product differentiation, route-to-market execution is a critical determinant of commercial success. Sales channel structures range from direct hospital partnerships and integrated imaging sales to distributor networks serving ambulatory and clinic environments. Service offerings that include training, maintenance, and consumable supply management are increasingly central to customer retention, and companies that align commercial incentives with clinical outcomes find it easier to negotiate value-based contracts.

Technology alliances are another key vector for competitive advantage. Collaborations with imaging manufacturers, cloud analytics providers, and clinical research networks accelerate time-to-evidence and broaden addressable use cases. Meanwhile, intellectual property around needle tip geometry, navigation algorithms, and software workflows creates defensive moats. The most resilient companies combine product excellence with scalable service models and a clear playbook for clinical validation across different procedure types and care settings.

Actionable multi-dimensional recommendations for manufacturers and healthcare leaders to secure supply resilience, clinical validation, and sustainable commercial differentiation

Industry leaders should adopt a multipronged strategy that balances near-term operational resilience with long-term platform differentiation. First, prioritize supply chain diversification and nearshoring where economically feasible to reduce exposure to trade policy volatility and to shorten lead times for critical components. This step should be accompanied by rigorous supplier qualification processes and scenario planning to maintain continuity for high-volume consumables such as needles and imaging accessories.

Second, invest in clinical evidence generation that aligns with the most commercially meaningful applications. Targeted prospective studies in breast, lung, liver, and prostate procedures that measure diagnostic yield, complication rates, and workflow efficiency will accelerate payer acceptance and hospital procurement decisions. Pair these studies with real-world evidence captured through integrated software to demonstrate longitudinal value.

Third, design modular platforms that enable cross-modal compatibility with CT, MRI, and ultrasound guidance. Such interoperability increases platform utilization across departments and improves return on capital for purchasers. Complement product modularity with flexible commercial models-leasing, outcome-based contracts, and bundled consumables-to address diverse purchasing preferences across hospitals, diagnostic centers, clinics, and ambulatory surgical centers.

Fourth, accelerate digital strategy by embedding guidance software, analytics, and remote support capabilities into product offerings. Digital features not only enhance procedural accuracy but also create recurring revenue pathways that are less sensitive to component tariffs. Finally, cultivate targeted channel partnerships and service infrastructures to ensure rapid deployment and high uptime in key regional markets, thereby strengthening customer loyalty and competitive differentiation.

A rigorous mixed-methods research framework that blends clinician interviews, supply chain analysis, regulatory review, and expert validation to ensure robust actionable insights

The research approach integrates qualitative and quantitative methods designed to triangulate market dynamics, clinical adoption drivers, and competitive positioning. Primary research included structured interviews with clinicians across specialties-radiology, interventional oncology, and urology-alongside procurement leaders at hospitals, ambulatory surgical centers, and diagnostic centers to capture firsthand perspectives on device requirements, workflow constraints, and purchasing criteria. These interviews were complemented by discussions with device engineers, regulatory specialists, and component suppliers to map development timelines and sourcing considerations.

Secondary research entailed systematic review of clinical literature, regulatory filings, and publicly available technical documentation to validate clinical claims and device feature sets. Where helpful, procedural guidelines and best-practice statements were synthesized to contextualize clinical utility. Data triangulation techniques were used to reconcile differing inputs, and sensitivity analysis framed how operational changes-such as tariff-driven cost pressures or shifts in reimbursement policy-could alter procurement calculus.

Throughout the process, findings were validated via expert panels comprising clinicians, health system administrators, and industry strategists to ensure pragmatic relevance. The methodology emphasizes transparency in assumptions, traceability of sources, and reproducibility of analytical steps so that stakeholders can apply insights directly to product planning, clinical trials design, and go-to-market execution.

A concise synthesis of clinical, technological, and strategic drivers that will determine which biopsy device strategies translate into sustained clinical adoption and commercial success

In summary, the evolution of smart biopsy devices reflects a broader shift toward integrated procedural solutions that combine precision guidance, optimized workflows, and software-enabled value capture. Clinical demand for minimally invasive, high-fidelity sampling is intersecting with technological progress in imaging and navigation, producing opportunities for differentiated platforms that can serve multiple applications and clinical environments. At the same time, external pressures-such as tariff changes and regional regulatory variation-are compelling manufacturers to reorient supply chains and commercial models to preserve margin and ensure uninterrupted clinical supply.

Moving forward, success will accrue to organizations that can demonstrate measurable clinical benefits, provide flexible commercial options tailored to diverse end users, and embed software-driven services that enhance procedural outcomes and create recurring revenue. The interplay between segmentation choices-product type, application, guidance technology, end-user, and component design-and regional strategy will determine which offerings scale effectively. For decision-makers, the imperative is to align R&D priorities with validated clinical needs, operational realities, and adaptable go-to-market tactics so that innovations translate into sustainable clinical adoption and long-term institutional partnerships.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence for enhanced real time image guided biopsy decisions
  • 5.2. Development of sensor embedded biopsy needles for precise tissue characterization and feedback
  • 5.3. Adoption of robotic assisted biopsy platforms to improve procedural accuracy and workflow efficiency
  • 5.4. Emergence of point of care integrated molecular diagnostics for immediate biopsy sample analysis and decision support
  • 5.5. Growing use of MRI ultrasound fusion techniques in smart biopsy systems for targeted cancer detection
  • 5.6. Introduction of disposable smart biopsy kits designed for infection control and cost effective single use procedures
  • 5.7. Expansion of cloud based data management and telemedicine integration for remote biopsy procedure oversight
  • 5.8. Increasing regulatory approvals and reimbursement coverage shaping smart biopsy device market growth dynamics
  • 5.9. Advances in deep learning algorithms for automated lesion detection and biopsy targeting recommendations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Smart Biopsy Devices Market, by Product Type

  • 8.1. Automated
  • 8.2. Manual

9. Smart Biopsy Devices Market, by Application

  • 9.1. Breast
  • 9.2. Liver
  • 9.3. Lung
  • 9.4. Prostate

10. Smart Biopsy Devices Market, by Guidance Technology

  • 10.1. CT Guided
  • 10.2. MRI Guided
  • 10.3. Ultrasound Guided

11. Smart Biopsy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals

12. Smart Biopsy Devices Market, by Component

  • 12.1. Accessories
  • 12.2. Guidance Software
  • 12.3. Imaging Systems
  • 12.4. Needles
    • 12.4.1. Large Gauge
    • 12.4.2. Medium Gauge
    • 12.4.3. Small Gauge

13. Smart Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Smart Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Smart Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. General Electric Company
    • 16.3.2. Siemens Healthineers AG
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. Hologic, Inc.
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. Hitachi, Ltd.
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. Cook Medical LLC
    • 16.3.10. Merit Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SMART BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SMART BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SMART BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 267. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GCC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. GCC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. GCC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 274. GCC SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 275. GCC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. GCC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 278. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 279. GCC SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 280. GCC SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 309. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. G7 SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. G7 SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. G7 SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. G7 SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. G7 SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. G7 SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. G7 SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. G7 SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 320. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 321. G7 SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 322. G7 SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 323. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. NATO SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. NATO SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. NATO SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. NATO SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. NATO SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 330. NATO SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 331. NATO SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. NATO SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 334. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 335. NATO SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 336. NATO SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 337. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. UNITED STATES SMART BIOPSY DEVICES MAR